Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2655.82 | 1445 / 1445 | 100% | 63.46 | 183 / 183 |
ovary | 100% | 1852.49 | 180 / 180 | 100% | 38.19 | 430 / 430 |
uterus | 100% | 1960.10 | 170 / 170 | 100% | 42.66 | 459 / 459 |
liver | 100% | 2284.86 | 226 / 226 | 100% | 30.35 | 405 / 406 |
stomach | 100% | 1809.03 | 359 / 359 | 100% | 54.04 | 285 / 286 |
adrenal gland | 100% | 2142.02 | 258 / 258 | 100% | 37.80 | 229 / 230 |
thymus | 100% | 1789.53 | 652 / 653 | 100% | 27.95 | 603 / 605 |
brain | 99% | 1925.08 | 2628 / 2642 | 100% | 33.91 | 705 / 705 |
intestine | 100% | 2489.49 | 966 / 966 | 99% | 58.51 | 524 / 527 |
prostate | 100% | 2438.55 | 245 / 245 | 99% | 34.29 | 498 / 502 |
pancreas | 99% | 1256.81 | 325 / 328 | 100% | 37.13 | 178 / 178 |
kidney | 100% | 1973.16 | 89 / 89 | 99% | 24.81 | 892 / 901 |
bladder | 100% | 2097.86 | 21 / 21 | 99% | 49.82 | 498 / 504 |
skin | 100% | 3739.92 | 1809 / 1809 | 99% | 36.50 | 466 / 472 |
breast | 100% | 2287.22 | 459 / 459 | 99% | 26.96 | 1103 / 1118 |
lung | 100% | 2276.90 | 576 / 578 | 99% | 37.47 | 1138 / 1155 |
eye | 0% | 0 | 0 / 0 | 100% | 28.63 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 60.51 | 29 / 29 |
muscle | 100% | 2786.60 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3360.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 50.76 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 60.91 | 1 / 1 |
adipose | 100% | 2057.83 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1884.29 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 2349.33 | 912 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 1471.64 | 845 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071629 | Biological process | cytoplasm protein quality control by the ubiquitin-proteasome system |
GO_0016567 | Biological process | protein ubiquitination |
GO_0042059 | Biological process | negative regulation of epidermal growth factor receptor signaling pathway |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0043162 | Biological process | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
GO_0042147 | Biological process | retrograde transport, endosome to Golgi |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0044314 | Biological process | protein K27-linked ubiquitination |
GO_0070534 | Biological process | protein K63-linked ubiquitination |
GO_1905168 | Biological process | positive regulation of double-strand break repair via homologous recombination |
GO_0035519 | Biological process | protein K29-linked ubiquitination |
GO_0006513 | Biological process | protein monoubiquitination |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005154 | Molecular function | epidermal growth factor receptor binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RNF126 |
Protein name | RING-type E3 ubiquitin transferase (EC 2.3.2.27) E3 ubiquitin-protein ligase RNF126 (EC 2.3.2.27) (RING finger protein 126) Ring finger protein 126 |
Synonyms | |
Description | FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination oF target proteins . Depending on the associated E2 ligase, mediates 'Lys-48'- and 'Lys-63'-linked polyubiquitination of substrates (By similarity). Part of a BAG6-dependent quality control process ensuring that proteins of the secretory pathway that are mislocalized to the cytosol are degraded by the proteasome. Probably acts by providing the ubiquitin ligase activity associated with the BAG6 complex and be responsible for ubiquitination of the hydrophobic mislocalized proteins and their targeting to the proteasome . May also play a role in the endosomal recycling of IGF2R, the cation-independent mannose-6-phosphate receptor . May play a role in the endosomal sorting and degradation of several membrane receptors including EGFR, FLT3, MET and CXCR4, by mediating their ubiquitination . By ubiquitinating CDKN1A/p21 and targeting it for degradation, may also promote cell proliferation . May monoubiquitinate AICDA . . |
Accessions | U3KQF4 K7EIY6 Q9BV68 ENST00000605891.5 ENST00000292363.10 ENST00000589762.5 |